Search Results

You are looking at 81 - 90 of 434 items for :

  • All content x
Clear All
Full access

Neel K. Gupta and Charalambos Andreadis

performed. He was asymptomatic, without palpable adenopathy or organomegaly, and was monitored expectantly during the next 5 years, remaining free of symptoms or hematologic abnormalities. By August 2009 he developed mild fatigue, cervical lymphadenopathy

Full access

Emily C. Harrold, Ahmad F. Idris, Niamh M. Keegan, Lynda Corrigan, Min Yuen Teo, Martin O’Donnell, Sean Tee Lim, Eimear Duff, Dearbhaile M. O’Donnell, M. John Kennedy, Sue Sukor, Cliona Grant, David G. Gallagher, Sonya Collier, Tara Kingston, Ann Marie O’Dwyer, and Sinead Cuffe

trajectory, with an impact on multiple functional domains and a deleterious effect on overall quality of life. 48 Improving sleep outcomes is significantly related to improvements in quality of life and reduced daytime fatigue. 49 Data also suggest an

Full access

Kerry Schaffer, Narmadha Panneerselvam, Kah Poh Loh, Rachel Herrmann, Ian R. Kleckner, Richard Francis Dunne, Po-Ju Lin, Charles E. Heckler, Nicholas Gerbino, Lauren B. Bruckner, Eugene Storozynsky, Bonnie Ky, Andrea Baran, Supriya Gupta Mohile, Karen Michelle Mustian, and Chunkit Fung

intensity as part of routine cancer care. Poor adherence to exercise interventions is a major barrier to achieving the optimal benefits of exercise. 13 – 16 The presence of symptoms related to cancer and its treatments, including fatigue, depression

Full access

Daniel C. McFarland, Heather Polizzi, John Mascarenhas, Marina Kremyanskaya, Jimmie Holland, and Ronald Hoffman

assessment of MPN-related symptom burden was captured using the Brief Fatigue Inventory (BFI) and the Functional Assessment of Cancer Therapy-Anemia (FACT-An). The most common symptoms were significant fatigue (81%), pruritus (53%), night sweats (49%), bone

Full access

1 or 2 toxicities included nausea, anorexia, dysphagia, dehydration, esophagitis, fatigue, constipation, and pain. Grade 3 toxicities included nausea, hyperglycemia, anemia, and leukopenia. One patient had grade 4 toxicity of hyponatremia. One

Full access

Arti Hurria, Ilene S. Browner, Harvey Jay Cohen, Crystal S. Denlinger, Mollie deShazo, Martine Extermann, Apar Kishor P. Ganti, Jimmie C. Holland, Holly M. Holmes, Mohana B. Karlekar, Nancy L. Keating, June McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O’Connor, Stephen H. Petersdorf, Hope S. Rugo, Rebecca A. Silliman, William P. Tew, Louise C. Walter, Alva B. Weir III, and Tanya Wildes

, depression, distress, osteoporosis, falls, fatigue, and frailty are some of the most common syndromes in elderly cancer patients. 97 Elderly patients with cancer experience a higher prevalence of geriatric syndromes compared with those without cancer. In

Full access

Arti Hurria, Tanya Wildes, Sarah L. Blair, Ilene S. Browner, Harvey Jay Cohen, Mollie deShazo, Efrat Dotan, Barish H. Edil, Martine Extermann, Apar Kishor P. Ganti, Holly M. Holmes, Reshma Jagsi, Mohana B. Karlekar, Nancy L. Keating, Beatriz Korc-Grodzicki, June M. McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O’Connor, Hope S. Rugo, Randall W. Rupper, Rebecca A. Silliman, Derek L. Stirewalt, William P. Tew, Louise C. Walter, Alva B. Weir III, Mary Anne Bergman, and Hema Sundar

, delirium, depression, distress, osteoporosis, falls, fatigue, and frailty are some of the most common syndromes in older patients with cancer. 93 Dementia and delirium are 2 of the most common causes of cognitive impairment. 94 Older patients with cancer

Full access

Presenter: Sandy Srinivas

-effect profiles,” Dr. Srinivas said. “The most important side effects of these drugs are fatigue, falls, and fractures.” However, the side-effect profiles of the drugs are somewhat different. The risk of fatigue is higher for apalutamide and enzalutamide (27

Full access

Michael H. Levy, Thomas Smith, Amy Alvarez-Perez, Anthony Back, Justin N. Baker, Susan Block, Shirley N. Codada, Shalini Dalal, Maria Dans, Jean S. Kutner, Elizabeth Kvale, Sumathi Misra, William Mitchell, Todd M. Sauer, David Spiegel, Linda Sutton, Robert M. Taylor, Jennifer Temel, Roma Tickoo, Susan G. Urba, Carin Van Zyl, Sharon M. Weinstein, Mary Anne Bergman, and Jillian L. Scavone

care, including pain, nausea, anxiety, depression, dyspnea, fatigue, psychosocial distress, and loss of appetite. 1 Palliative care in oncology began as hospice and end-of-life care. During the past 20 years, increasing attention has been paid to the

Full access

Karen E. Kinahan, Sheetal Kircher, Jessica Altman, Alfred Rademaker, John M. Salsman, Aarati Didwania, Bridget O'Brien, Alpa C. Patel, and Stacy D. Sanford

– 29 Other literature on the use of BPAs highlight “alert fatigue,” which occurs when providers are inundated with too many BPAs and ignore them or work around them. 30 , 31 There was evidence of alert fatigue in our study based on the providers